Literature DB >> 26714942

Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach.

Qi-Yue Chen1, Chang-Ming Huang2, Jian-Xian Lin1, Chao-Hui Zheng1, Ping Li1, Jian-Wei Xie1, Jia-Bin Wang1, Jun Lu1, Xin-Tao Yang1.   

Abstract

BACKGROUND: We developed a procedure for laparoscopic infrapyloric area lymph node (LN) dissection with No. 14v enlargement, which is complicated for patients with advanced lower gastric cancer (GC) (Xu et al., World J Gastroenterol 13:5133-5138,2007; Masuda et al., Dig Surg 25:351-358,2008; An et al., Br J Surg 98:667-672,2011].
METHODS: From April 2008 to December 2014, 1096 patients with GC underwent laparoscopy-assisted radical distal gastrectomy in our department. According to the Japanese GC treatment guidelines, D2 (+No. 14v) may be beneficial in tumors with apparent metastasis to the No. 6 nodes (Japanese Gastric Cancer Association, Gastric Cancer 14:113-123,2010). Thus, 151 advanced lower GC patients with apparent metastasis to the No. 6 nodes underwent additional No. 14v LN dissection. We dissected infrapyloric area LNs with No. 14v dissection from the left to the right side (i.e., middle colic vein approach).
RESULTS: Mean operation time was 22.8 ± 10.0 min, mean blood loss was 17.1 ± 14.6 ml, and mean times to first flatus, fluid diet, and soft diet were 3.7 ± 1.2 days, 5.0 ± 1.7 days, and 8.4 ± 1.6 days, respectively. A mean of 33.7 ± 11.2 LNs were retrieved, including 3.9 ± 2.7 No. 6 LNs and 2.0 ± 1.6 No. 14v LNs. Of 151 patients, 26 had No. 14v metastasis (17.2%), and 43 (28.5%) were accompanied by an extensive infrapyloric area nodal involvement. The overall postoperative morbidity rate was 10.6% (16 of 151). At a median follow-up of 56 months (range 5-84 months), cumulative 3-year overall survival was 56.0%.
CONCLUSIONS: Although it remains controversial whether prophylactic No. 14v dissection improves survival, laparoscopic infrapyloric area LN dissection using a middle colic vein approach may be safely achieved and is more convenient for advanced lower GC.

Entities:  

Mesh:

Year:  2015        PMID: 26714942     DOI: 10.1245/s10434-015-4992-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Development of lymph node dissection in laparoscopic gastrectomy: safety and technical tips.

Authors:  Ru-Hong Tu; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Chang-Ming Huang; Chao-Hui Zheng
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-30

2.  Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case-control study.

Authors:  Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

3.  Which method is more suitable for advanced gastric cancer with enlarged lymph nodes, laparoscopic radical gastrectomy or open gastrectomy?

Authors:  Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang
Journal:  Gastric Cancer       Date:  2018-01-30       Impact factor: 7.370

4.  Do preoperative enlarged lymph nodes affect the oncologic outcome of laparoscopic radical gastrectomy for gastric cancer?

Authors:  Qi-Yue Chen; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu
Journal:  Oncotarget       Date:  2017-01-31

5.  Characteristics and survival outcomes related to the infra-pyloric lymph node status of gastric cancer patients.

Authors:  Wei-Han Zhang; Xiao-Hai Song; Xin-Zu Chen; Kun Yang; Kai Liu; Zhi-Xin Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  World J Surg Oncol       Date:  2018-06-20       Impact factor: 2.754

6.  Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study.

Authors:  Pengfei Yu; Yian Du; Zhiyuan Xu; Ling Huang; Xiangdong Cheng
Journal:  World J Surg Oncol       Date:  2019-02-06       Impact factor: 2.754

7.  "D2 plus" lymphadenectomy is associated with improved survival in distal gastric cancer with clinical serosa invasion: a propensity score analysis.

Authors:  Yuexiang Liang; Jingli Cui; Yaoqing Cai; Lijie Liu; Jianghao Zhou; Qiang Li; Junmei Wu; Donglei He
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

8.  A Novel Insight Into Fecal Occult Blood Test for the Management of Gastric Cancer: Complication, Survival, and Chemotherapy Benefit After R0 Resection.

Authors:  Jun Lu; Binbin Xu; Yu Xu; Yuan Wu; Jianwei Xie; Jiabin Wang; Jianxian Lin; Qiyue Chen; Longlong Cao; Chaohui Zheng; Changming Huang; Ping Li
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

Review 9.  Current status of extended 'D2 plus' lymphadenectomy in advanced gastric cancer.

Authors:  Jing-Quan Li; Donglei He; Yue-Xiang Liang
Journal:  Oncol Lett       Date:  2021-04-12       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.